Maintain "Confidence Bylvay Could Become the Best-in-Class Agent" - William Blair Reiterates Outperform Rating on Albireo Pharma (ALBO)
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on Albireo Pharma (NASDAQ: ALBO), following the company's recent presentation at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
